Return of induction chemotherapy in head and neck squamous cell cancers: is this time different?

Affiliations

¹ Department of Radiation and Cellular Oncology, University of Chicago Medical Center, Chicago, IL 60637, USA; Department of Radiation Oncology, University of Illinois Hospital and Health Sciences System, Chicago, IL, USA. Electronic address: mspiotto@radonc.uchicago.edu.

Comment

Michael T Spiotto. Lancet Oncol. 2016 Nov.

. 2016 Nov;17(11):1465-1467.

doi: 10.1016/S1470-2045(16)30444-2. Epub 2016 Sep 27.

¹ Department of Radiation and Cellular Oncology, University of Chicago Medical Center, Chicago, IL 60637, USA; Department of Radiation Oncology, University of Illinois Hospital and Health Sciences System, Chicago, IL, USA. Electronic address: mspiotto@radonc.uchicago.edu.

No abstract available

Comment on

Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial.
Sun Y, Li WF, Chen NY, Zhang N, Hu GQ, Xie FY, Sun Y, Chen XZ, Li JG, Zhu XD, Hu CS, Xu XY, Chen YY, Hu WH, Guo L, Mo HY, Chen L, Mao YP, Sun R, Ai P, Liang SB, Long GX, Zheng BM, Feng XL, Gong XC, Li L, Shen CY, Xu JY, Guo Y, Chen YM, Zhang F, Lin L, Tang LL, Liu MZ, Ma J. Sun Y, et al. Lancet Oncol. 2016 Nov;17(11):1509-1520. doi: 10.1016/S1470-2045(16)30410-7. Epub 2016 Sep 27. Lancet Oncol. 2016. PMID: 27686945 Clinical Trial.